(Q34743245)

4 August 2017

1 reference

title

Genome-based pharmacogenetics and the pharmaceutical industry (English)

1 reference

4 August 2017

Allen D Roses

1

1 reference

4 August 2017

1 July 2002

1 reference

Nature Reviews Drug Discovery

4 August 2017

1 reference

4 August 2017

1

1 reference

4 August 2017

541-549

1 reference

4 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd840

4 August 2017

0 references

cites work

A SNPshot: pharmacogenetics and the future of drug therapy

1 reference

Adverse drug reactions: definitions, diagnosis, and management

31 March 2020

1 reference

Pharmacogenomics: unlocking the human genome for better drug therapy

31 March 2020

1 reference

Pharmacogenetics and the practice of medicine

31 March 2020

1 reference

31 March 2020

1 reference

Pharmacogenomics: the inherited basis for interindividual differences in drug response

31 March 2020

1 reference

Genetic susceptibility to adverse drug reactions

31 March 2020

1 reference

Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial.

31 March 2020

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

31 March 2020

1 reference

New active substances authorized in the United Kingdom between 1972 and 1994.

31 March 2020

1 reference

31 March 2020

Adverse drug reactions

1 reference

Pharmacogenomics: will it change the field of medicine?

31 March 2020

1 reference

Pharmacogenomic-guided drug development: regulatory perspective

31 March 2020

1 reference

Pharmacogenetics place in modern medical science and practice

31 March 2020

1 reference

A 4-Mb high-density single nucleotide polymorphism-based map around human APOE

31 March 2020

1 reference

Apolipoprotein E alleles as risk factors in Alzheimer's disease

31 March 2020

1 reference

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

31 March 2020

1 reference

The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics

31 March 2020

1 reference

Association between apolipoprotein E genotype and Alzheimer disease in African American subjects

31 March 2020

1 reference

SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease

31 March 2020

1 reference

Analysis of association at single nucleotide polymorphisms in the APOE region.

31 March 2020

1 reference

Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine.

31 March 2020

1 reference

Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map.

31 March 2020

1 reference

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease

31 March 2020

1 reference

The genetics of allergic contact hypersensitivity to nickel

31 March 2020

1 reference

Patterns of linkage disequilibrium in the human genome

31 March 2020

1 reference

31 March 2020

1 reference

Risk factor analysis of hypersensitivity reactions to abacavir

31 March 2020

1 reference

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

31 March 2020

1 reference

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

31 March 2020

1 reference

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

31 March 2020

1 reference

Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome

31 March 2020

1 reference

Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.

31 March 2020

1 reference

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome

31 March 2020

1 reference

Sequence of exons and the flanking regions of human bilirubin-UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I

31 March 2020

1 reference

Pharmacogenetics and future drug development and delivery

31 March 2020

1 reference

Use of proteomic patterns in serum to identify ovarian cancer

31 March 2020

1 reference

Pharmacogenetic challenges for the health care system

31 March 2020

1 reference

Science, medicine, and the future: Pharmacogenetics

31 March 2020

1 reference

Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy

31 March 2020

1 reference

Toxicogenetics in drug development

31 March 2020

1 reference

Testing drug response in the presence of genetic information: sampling issues for clinical trials

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD840

1 reference

4 August 2017

1 reference

PubMed ID

12120260